Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3914

1.

Functional evaluation of variants of unknown significance in the BRCA2 gene identified in genetic testing.

Heczkova M, Machackova E, Macinga P, Gallmeier E, Cahova M, Spicak J, Jirsa M, Foretova L, Hucl T.

Cancer Biol Ther. 2019 Jan 13:1-9. doi: 10.1080/15384047.2018.1550566. [Epub ahead of print]

PMID:
30638113
2.

Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer.

Willumsen N, Jorgensen LN, Karsdal MA.

Cancer Biol Ther. 2019 Jan 9:1-8. doi: 10.1080/15384047.2018.1550571. [Epub ahead of print]

PMID:
30626261
3.

Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits.

Zhang X, Dai F, Chen J, Xie X, Xu H, Bai C, Qiao W, Shen W.

Cancer Biol Ther. 2019 Jan 8:1-11. doi: 10.1080/15384047.2018.1550567. [Epub ahead of print]

PMID:
30621501
4.

Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.

Wang J, Wang X, Wang Y, Li S, Wang X.

Cancer Biol Ther. 2018 Dec 27:1-12. doi: 10.1080/15384047.2018.1550570. [Epub ahead of print]

PMID:
30590988
5.

LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases.

Pan J, Zhang D, Zhang J, Qin P, Wang J.

Cancer Biol Ther. 2018 Dec 24:1-13. doi: 10.1080/15384047.2018.1550568. [Epub ahead of print]

PMID:
30582709
6.

Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway.

Weng YC, Ma J, Zhang J, Wang JC.

Cancer Biol Ther. 2018 Dec 22:1-13. doi: 10.1080/15384047.2018.1529110. [Epub ahead of print]

PMID:
30580676
7.

Combined α-programmed death-1 monoclonal antibody blockade and fractionated radiation therapy reduces tumor growth in mouse EL4 lymphoma.

Lin X, Zeng T, Xiong J, Zhang Q, Jiang P, Li X, Lin S, Xu Q, Weng H, Lai H, Gong H, Lin J, Cheng N, Tian X, Xu Y, Fang S, Jin R, Chen Z, Yang J, Morton L, Yueh B, Lin J.

Cancer Biol Ther. 2018 Dec 20:1-14. doi: 10.1080/15384047.2018.1550569. [Epub ahead of print]

PMID:
30572778
8.

Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.

Ye Z, Ding Y, Chen Z, Li Z, Ma S, Xu Z, Cheng L, Wang X, Zhang X, Ding N, Zhang Q, Qian Q.

Cancer Biol Ther. 2018 Dec 20:1-6. doi: 10.1080/15384047.2018.1538000. [Epub ahead of print]

PMID:
30572767
9.

Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells.

Booth L, Roberts JL, Sander C, Lalani AS, Kirkwood JM, Hancock JF, Poklepovic A, Dent P.

Cancer Biol Ther. 2018 Dec 20:1-11. doi: 10.1080/15384047.2018.1551747. [Epub ahead of print]

PMID:
30571927
10.

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.

Zheng D, Chang X, Liu Y, Xu J, Gou W, Li Z, Zuo D, Zhang W, Wu Y.

Cancer Biol Ther. 2018 Dec 4:1-11. doi: 10.1080/15384047.2018.1537578. [Epub ahead of print]

PMID:
30514153
11.

Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Li C, Zhang S, Qiu T, Wang Y, Ricketts DM, Qi C.

Cancer Biol Ther. 2018 Nov 29:1-10. doi: 10.1080/15384047.2018.1538612. [Epub ahead of print]

PMID:
30489194
12.

Discovery platform for inhibitors of IgH gene enhancer activity.

Dolloff NG.

Cancer Biol Ther. 2018 Nov 27:1-11. doi: 10.1080/15384047.2018.1538615. [Epub ahead of print]

PMID:
30481117
13.

LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.

Wang L, Shang X, Feng Q.

Cancer Biol Ther. 2018 Nov 27:1-11. doi: 10.1080/15384047.2018.1529091. [Epub ahead of print]

PMID:
30481109
14.

Successful treatment of a BRAF V600E-mutant extracranial metastatic anaplastic oligoastrocytoma with vemurafenib and everolimus.

Shi L, Zou Z, Ding Q, Liu Q, Zhou H, Hong X, Peng G.

Cancer Biol Ther. 2018 Nov 21:1-4. doi: 10.1080/15384047.2018.1529115. [Epub ahead of print]

PMID:
30462564
15.

Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.

Fan Y, Li M, Ma K, Hu Y, Jing J, Shi Y, Li E, Dong D.

Cancer Biol Ther. 2018 Nov 21:1-16. doi: 10.1080/15384047.2018.1539290. [Epub ahead of print]

PMID:
30462562
16.

Crosstalk between TF/FVIIa and EGFR signaling in colorectal cancer cells.

Chen HK, Wang X, Wan YL, Tang JQ.

Cancer Biol Ther. 2018 Nov 21:1-7. doi: 10.1080/15384047.2018.1529123. [Epub ahead of print]

PMID:
30462558
17.

Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1.

Liu G, Zhao X, Zhou J, Cheng X, Ye Z, Ji Z.

Cancer Biol Ther. 2018 Nov 21:1-18. doi: 10.1080/15384047.2018.1480279. [Epub ahead of print]

PMID:
30461333
18.

New onset acute promyelocytic Leukemia during pregnancy: report of 2 cases.

Li H, Han C, Li K, Li J, Wang Y, Xue F.

Cancer Biol Ther. 2018 Nov 19:1-5. doi: 10.1080/15384047.2018.1529122. [Epub ahead of print]

PMID:
30453810
19.

Discovery of a novel DNA polymerase inhibitor and characterization of its antiproliferative properties.

Mishra B, Zhang S, Zhao H, Darzynkiewicz Z, Lee EYC, Lee MYWT, Zhang Z.

Cancer Biol Ther. 2018 Nov 14:1-13. doi: 10.1080/15384047.2018.1529126. [Epub ahead of print]

PMID:
30427259
20.

IR-A/IGF-1R-mediated signals promote epithelial-mesenchymal transition of endometrial carcinoma cells by activating PI3K/AKT and ERK pathways.

Wang C, Su K, Zhang Y, Zhang W, Zhao Q, Chu D, Guo R.

Cancer Biol Ther. 2018 Nov 14:1-12. doi: 10.1080/15384047.2018.1529096. [Epub ahead of print]

PMID:
30426831

Supplemental Content

Loading ...
Support Center